WARNING : Accidental overdose of iron - containing products is a leading cause of fatal poisoning in children under 6 .
KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN .
In case of accidental overdose , call a doctor or poison control center immediately .
DESCRIPTION CitraNatal ® 90 DHA is a prescription prenatal / postnatal multivitamin / mineral tablet with Ferr - Ease ® , a patented dual - iron delivery comprising both a quick release and slow release iron , and a capsule of an essential fatty acid .
The prenatal vitamin is a scored , white , oval multivitamin / mineral tablet .
The tablet is debossed “ CN 90 ” on one side and “ 08 ” bisect “ 29 ” on the other .
The essential fatty acid DHA capsule is caramel colored and contains a light yellow to orange semi - solid mixture .
Each prenatal tablet contains : Vitamin C ( Ascorbic acid ) 120 mg Calcium ( Calcium citrate ) 160 mg Iron ( Carbonyl iron , ferrous gluconate ) 90 mg Vitamin D3 ( Cholecalciferol ) 400 IU Vitamin E ( dl - alpha tocopheryl acetate ) 30 IU Thiamin ( Vitamin B1 ) 3 mg Riboflavin ( Vitamin B2 ) 3 . 4 mg Niacinamide ( Vitamin B3 ) 20 mg Vitamin B6 ( Pyridoxine HCl ) 20 mg Folic Acid 1 mg Iodine ( Potassium iodide ) 150 mcg Zinc ( Zinc oxide ) 25 mg Copper ( Cupric oxide ) 2 mg Docusate Sodium 50 mg Each DHA gelatin capsule contains : Docosahexaenoic Acid ( DHA , 40 % from 750 mg Algal Oil ) ................................... 300 mg Eicosapentaenoic Acid ( EPA ) .................. Not more than 0 . 750 mg Other ingredients in DHA gelatin capsule : High Oleic Sunflower Oil , Sunflower Lecithin , Rosemary Extract , Tocopherols , Ascorbyl Palmitate .
indications CitraNatal ® 90 DHA is a multivitamin / mineral prescription drug indicated for use in improving the nutritional status of women prior to conception , throughout pregnancy , and in the postnatal period for both lactating and nonlactating mothers .
CONTRAINDICATIONS This product is contraindicated in patients with a known hypersensitivity to any of the ingredients .
WARNING Ingestion of more than 3 grams of omega - 3 fatty acids per day has been shown to have potential antithrombotic effects , including an increased bleeding time and INR .
Administration of omega - 3 fatty acids should be avoided in patients on anticoagulants and in those known to have an inherited or acquired bleeding diathesis .
WARNING : Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient .
PRECAUTIONS Folic acid in doses above 0 . 1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress .
ADVERSE REACTIONS Allergic sensitization has been reported following both oral and parenteral administration of folic acid .
DOSAGE AND ADMINISTRATION One tablet and one capsule daily or as directed by a physician .
STORAGE Store at 20 - 25 ° C ( 68 - 77 ° F ) NOTICE : Contact with moisture can discolor or erode the tablet .
HOW SUPPLIED Six child - resistant blister packs of 5 tablets and 5 capsules each - NDC 0178 - 0829 - 30 To report a serious adverse event or obtain product information , call ( 210 ) 696 - 8400 .
50261 C01 Rev 011110 DHA capsules manufactured for : MISSION PHARMACAL COMPANY San Antonio , TX USA 78230 1355 Prenatal tablets manufactured by : MISSION PHARMACAL COMPANY San Antonio , TX USA 78230 1355 CitraNatal ® 90 DHA Carton NDC : 0178 - 0829 - 30 [ MULTIMEDIA ] [ MULTIMEDIA ]
